Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism JAK3 inhibitors(Tyrosine-protein kinase JAK3 inhibitors), MAP3K11 inhibitors(Mitogen-activated protein kinase kinase kinase 11 inhibitors), TYK2 inhibitors(Tyrosine-protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | ES | - | |
Inflammation | Preclinical | ES | - |